Concord Biotech Ltd NSE:CONCORDBIO:
CONCORD BIOTECH - COMPLETES PPB (KENYA) AND NDA (UGANDA) INSPECTION AT UNIT-II FORMULATION FACILITY
Concord Biotech Completes PPB (Kenya) And NDA (Uganda) Inspection At Unit-Ii Formulation Facility
Watch Concord Biotech's latest callConcord Biotech (NSE:CONCORDBIO) Q2 2027 Earnings Call · Replay · Oct 28Read the transcript of Concord Biotech (NSE:CONCORDBIO) Q2 2027 Earnings CallEarlier from Concord Biotech
- Bertelsmann says US authorities have approved BMG/Concord merger
- Concord Biotech Completes Anvisa Inspection At Limbasi API Manufacturing Facility
- Trade Spotlight: How should you trade Concord Biotech, Jindal Steel, Axis Bank, Aegis Logistics, Raymond, and others on June 11?
- Concord Biotech surges over 5% after USFDA approval for Tofacitinib tablets
- Concord Biotech shares jump 8% after US FDA clears firm's new drug
Follow Concord Biotech into a list and get an email when it puts out news.
Follow Concord Biotech